Vincent Billoet

Vincent Billoet is a seasoned professional in pharmaceutical development, currently serving as Pharmaceutical Development Leader at the Drugs for Neglected Diseases initiative (DNDi) since April 2023. Prior roles include Innovation & IP Lead at OM Pharma, where Vincent led the development of four New Chemical Entities for First in Human studies, and R&D Director at GSK, overseeing new product development in the Cough & Cold and Nasal Health categories. With substantial experience at Novartis Consumer Health, Ethypharm, Merck Animal Health, and Pfizer Pharmaceuticals, Vincent has a proven track record in innovative formulation projects, project leadership, team management, and collaboration across global R&D teams. Vincent holds a Pharm D from Université de Tours along with degrees in Pharmaceutical Manufacturing and Quality Assurance and in Formulation Development and Manufacturing of Pharmaceuticals.